Zacks.com on MSN1h
AbbVie's Ovarian Cancer Drug Elahere Gets Approval in EuropeThe EC has approved Elahere for treating adult patients with folate receptor-alpha (FRα) positive, platinum-resistant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback